Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
MGX
Metagenomi Therapeutics Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Metagenomi Therapeutics Inc (MGX) Earnings
Last reported
May 19, 2026
EPS estimate
-$0.53
EPS actual
—
Revenue est.
$6.0M
Revenue actual
—
Related:
MGX overview
·
MGX financials
·
MGX news